tert-butyl N-(2-anilinophenyl)glycinate 、 丙二酰氯 在
resultant material 、 silica gel 作用下,
以
四氢呋喃 为溶剂,
反应 20.33h,
以to give 10.2 g of product的产率得到tert-butyl (2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)acetate
The present invention provides a compound of formula I comprising:
a pharmaceutically acceptable salt, solvate, or physiologically functional derivative thereof.